43.6486362, -79.3817439

366 Bay Street,
Suite 301,
Toronto, ON, M5H 4B2, Canada

SOL Investments Corp - Ordinary Shares

About Us

Scythian Biosciences Corp is a pre-clinical research and development company. It is engaged in the process of development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury.

SOL Global Investments Corp. operates as a cannabis company in the United States. The company was formerly known as Scythian Biosciences Corp. and changed its name to SOL Global Investments Corp. in October 2018.

SOL Investments Corp - Ordinary Shares